Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02981303 |
Title | Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Biothera |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Arizona Center for Cancer Care | Avondale | Arizona | 85392 | United States | Details | |
John Wayne Cancer Institute | Santa Monica | California | 90404 | United States | Details | |
University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
Sarah Cannon Research Institute | Denver | Colorado | 80218 | United States | Details | |
University Cancer and Blood Center | Athens | Georgia | 30607 | United States | Details | |
Piedmont Cancer Institute | Atlanta | Georgia | 30318 | United States | Details | |
Stony Brook University Cancer Center | Stony Brook | New York | 11794 | United States | Details | |
Thomas Jefferson University Sidney Kimmel Cancer Center | Philadelphia | Pennsylvania | 19107 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Millennium Oncology | Houston | Texas | 77090 | United States | Details |